Mr. Don Cilla reports

APPILI THERAPEUTICS - PRESS RELEASE CORRECTION

Appili Therapeutics Inc. has issued a correction to its press release entitled "Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders," issued on Oct. 10, 2024.

The initial press release, incorrectly stated that, under the terms of the proposed arrangement with Aditxt Inc. for each Class A common share of the company, shareholders will receive (i) 46.7 U.S. cents in cash and (ii) 0.00686251 U.S. cent of a share of Aditxt common stock (representing a value of approximately 0.013 U.S. cent per Appili share based on the closing price of the Aditxt shares on Oct. 3, 2024). The reference to 46.7 U.S. cents of cash consideration in the initial press release was in error and such cash amount for each Appili share should read 4.67 U.S. cents.

We seek Safe Harbor.